Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Cash on Hand 2009–2025
Neurocrine Biosciences Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Neurocrine Biosciences Inc. cash on hand for the quarter ending December 31, 2025 were 713.0M, a 206.01% increase year-over-year.
- Neurocrine Biosciences Inc. cash on hand for 2025 were 713.0M, a 206.01% increase from 2024.
- Neurocrine Biosciences Inc. cash on hand for 2024 were 233.0M, a 7.21% decrease from 2023.
- Neurocrine Biosciences Inc. cash on hand for 2023 were 251.1M, a 4.49% decrease from 2022.
- Neurocrine Biosciences Inc. cash on hand for 2022 were 262.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Neurocrine Biosciences Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $713 |
| 2024 | $233 |
| 2023 | $251 |
| 2022 | $263 |
| 2021 | $341 |
| 2020 | $187 |
| 2019 | $112 |
| 2018 | $142 |
| 2017 | $255 |
| 2016 | $83 |
| 2015 | $74 |
| 2014 | $31 |
| 2013 | $45 |
| 2012 | $64 |
| 2011 | $50 |
| Neurocrine Biosciences Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $713 |
| 2024-12-31 | $233 |
| 2023-12-31 | $251 |
| 2022-12-31 | $263 |
| 2021-12-31 | $341 |
| 2020-12-31 | $187 |
| 2019-12-31 | $112 |
| 2018-12-31 | $142 |
| 2017-12-31 | $255 |
| 2016-12-31 | $83 |
| 2015-12-31 | $74 |
| 2014-12-31 | $31 |
| 2013-12-31 | $45 |
| 2012-12-31 | $64 |
| 2011-12-31 | $50 |
| 2010-12-31 | $54 |
Neurocrine Biosciences Inc. Cash on Hand — FAQ
Neurocrine Biosciences Inc. (NBIX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's cash on hand history?
The chart and table above show Neurocrine Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.